# Ferroptosis as a therapeutic nexus: traditional Chinese medicine interventions in rheumatoid arthritis

**Authors:** Ruibin Yang, Ziwei Yang, Zhuan Feng, Yaxin Ding, Jiali Yang, Yinuo Zhang, Zhi-Nan Chen, Fei Huo, Jiao Wu

PMC · DOI: 10.3389/fimmu.2026.1768013 · Frontiers in Immunology · 2026-02-19

## TL;DR

This review explores how traditional Chinese medicine can treat rheumatoid arthritis by targeting ferroptosis, a type of cell death linked to iron metabolism and immune regulation.

## Contribution

The paper systematically reviews how TCM modulates ferroptosis pathways to treat rheumatoid arthritis, offering new therapeutic insights.

## Key findings

- TCM regulates iron metabolism and activates antioxidant pathways to alleviate RA symptoms.
- Ferroptosis pathways, including NCOA4-mediated ferritin autophagy, are dysregulated in RA.
- Modulating ferroptosis provides a novel therapeutic strategy for RA treatment.

## Abstract

Ferroptosis is an iron-dependent, lipid peroxidation-driven form of programmed cell death that plays an important role in neurodegenerative, neoplastic, and autoimmune diseases. Recent studies in Rheumatoid arthritis (RA) have shown that iron metabolism disorders caused by iron overload and impaired transferrin function lead to the production of reactive oxygen species; ferroptosis-associated pathways, such as dysregulation of the System Xc-/GPX4 axis dysregulation, NCOA4-mediated ferritin autophagy, endoplasmic reticulum stress and ferroptosis pathway crosstalk; as well as ferroptosis plays a regulatory role in a variety of immune cells, such as T-cells, B-cells, macrophages, etc., which collectively constitute a complex disease regulatory network in RA. Studies have shown that traditional Chinese medicine (TCM) and TCM therapeutics can alleviate RA-related symptoms and improve the disease progression and prognosis of RA by regulating iron metabolism, activating the Nrf2/HO-1 antioxidant pathway, and removing abnormally proliferating synovial fibroblasts (FLS cells). The aim of this review is to comprehensively summarize the therapeutic potential of TCM for RA using ferroptosis as a therapeutic pathway. The aim is to provide a scientific basis for the clinical application of TCM in RA. In major scientific databases (including PubMed, Web of Science, ScienceDirect, and CNKI, covering literature published up to June 2025). The search strategy combines “Chinese medicine”, “TCM”, “ferroptosis”, and “rheumatoid arthritis”, using Boolean operators (AND, OR). This review systematically elucidates the mechanistic underpinnings through which TCM mitigates RA by modulating ferroptosis pathways. This review highlights the potential that Chinese medicine holds in the treatment of RA. The use of ferroptosis as a therapeutic pivot provides new ideas for the treatment of RA and promotes the integration of Western and Chinese medicine.

## Linked entities

- **Proteins:** GPX4 (glutathione peroxidase 4), NCOA4 (nuclear receptor coactivator 4), GABPA (GA binding protein transcription factor subunit alpha), HMOX1 (heme oxygenase 1)
- **Diseases:** rheumatoid arthritis (MONDO:0008383)

## Full-text entities

- **Genes:** Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Il18 (interleukin 18) [NCBI Gene 16173] {aka Igif, Il-18}, Trp53-ps (transformation related protein 53, pseudogene) [NCBI Gene 22060], TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, Nfkbia (nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha) [NCBI Gene 18035] {aka Nfkbi}, SEMA5A (semaphorin 5A) [NCBI Gene 9037] {aka SEMAF, semF}, Sqstm1 (sequestosome 1) [NCBI Gene 18412] {aka A170, OSF-6, Osi, STAP, STONE14, p62}, Etv4 (ETS variant transcription factor 4) [NCBI Gene 360635] {aka Pea3}, Fap (fibroblast activation protein) [NCBI Gene 14089] {aka SIMP}, FAP (fibroblast activation protein alpha) [NCBI Gene 2191] {aka DPPIV, FAPA, FAPalpha, SIMP}, E2f1 (E2F transcription factor 1) [NCBI Gene 13555] {aka E2F-1, Tg(Wnt1-cre)2Sor, mKIAA4009}, Gpbar1 (G protein-coupled bile acid receptor 1) [NCBI Gene 338443] {aka M-BAR, Tgr5}, Slc7a11 (solute carrier family 7 (cationic amino acid transporter, y+ system), member 11) [NCBI Gene 26570] {aka 9930009M05Rik, sut, xCT}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, Hmox1 (heme oxygenase 1) [NCBI Gene 15368] {aka D8Wsu38e, HO-1, HO1, Hemox, Hmox, Hsp32}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, Mmp3 (matrix metallopeptidase 3) [NCBI Gene 17392] {aka EMS-2, MMP-3, SL-1, SLN-1, SLN1, STR-1}, ALOX5 (arachidonate 5-lipoxygenase) [NCBI Gene 240] {aka 5-LO, 5-LOX, 5LPG, LOG5}, Keap1 (kelch-like ECH-associated protein 1) [NCBI Gene 50868] {aka INRF2, mKIAA0132}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Il1b (interleukin 1 beta) [NCBI Gene 24494] {aka IL-1F2}, FTH1 (ferritin heavy chain 1) [NCBI Gene 2495] {aka FHC, FTH, FTHL6, HFE5, NBIA9, PIG15}, Gpx4 (glutathione peroxidase 4) [NCBI Gene 29328] {aka Gshpx-4, Phgpx, gpx-4, snGpx}, NCOA4 (nuclear receptor coactivator 4) [NCBI Gene 8031] {aka ARA70, ELE1, PTC3, RFG}, MMP3 (matrix metallopeptidase 3) [NCBI Gene 4314] {aka CHDS6, MMP-3, SL-1, STMY, STMY1, STR1}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, SLC7A11 (solute carrier family 7 member 11) [NCBI Gene 23657] {aka CCBR1, xCT}, Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 287362] {aka Cias1}, ATM (ATM serine/threonine kinase) [NCBI Gene 472] {aka AT1, ATA, ATC, ATD, ATDC, ATE}, Nfe2l2 (nuclear factor, erythroid derived 2, like 2) [NCBI Gene 18024] {aka Nrf2}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Hmox1 (heme oxygenase 1) [NCBI Gene 24451] {aka HEOXG, Heox, Hmox, Ho-1, Ho1, hsp32}, Slc7a11 (solute carrier family 7 member 11) [NCBI Gene 310392], Cxcl15 (C-X-C motif chemokine ligand 15) [NCBI Gene 20309] {aka Il8, Scyb15, lungkine, weche}, Hmgb1 (high mobility group box 1) [NCBI Gene 15289] {aka HMG-1, Hmg1, SBP-1, p30}, Rela (Rela proto-oncogene, NFKB subunit) [NCBI Gene 19697] {aka p65, p65 NF-kappa B, p65 NFkB}, Nfe2l2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 83619], GPX4 (glutathione peroxidase 4) [NCBI Gene 2879] {aka GPx-4, GSHPx-4, MCSP, PHGPx, SMDS, snGPx}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, HMOX1 (heme oxygenase 1) [NCBI Gene 3162] {aka HMOX1D, HO-1, HSP32, bK286B10}, Stat3 (signal transducer and activator of transcription 3) [NCBI Gene 20848] {aka 1110034C02Rik, Aprf}, Gpx4 (glutathione peroxidase 4) [NCBI Gene 625249] {aka GPx-4, GSHPx-4, PHGPx, mtPHGPx, snGPx}, Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}, Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 216799] {aka AGTAVPRL, AII/AVP, Cias1, FCAS, FCU, MWS}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, ACSL4 (acyl-CoA synthetase long chain family member 4) [NCBI Gene 2182] {aka ACS4, FACL4, LACS4, MRX63, MRX68, XLID63}, Il17a (interleukin 17A) [NCBI Gene 301289] {aka CTLA-8, IL-17, IL-17A, Il17}, Keap1 (Kelch-like ECH-associated protein 1) [NCBI Gene 117519] {aka Inrf2}, PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1) [NCBI Gene 5562] {aka AMPK, AMPK alpha 1, AMPKa1}, Prdx6-ps2 (peroxiredoxin 6 pseudogene 2) [NCBI Gene 384001] {aka Aop2-rs2, GPx*, Prdx6-rs2}, TF (transferrin) [NCBI Gene 7018] {aka HEL-S-71p, PRO1557, PRO2086, TFQTL1}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Prdx2 (peroxiredoxin 2) [NCBI Gene 21672] {aka Band-8, NkefB, PRP, PrxII, TDX1, TPx}
- **Diseases:** cartilage (MESH:D002357), acute (MESH:D000208), metabolic disorder (MESH:D008659), OA (MESH:D010003), ankylosis (MESH:D000844), autoimmune disease (MESH:D001327), swelling (MESH:D004487), CIA (MESH:D001169), inflammatory malignancy (MESH:D009369), mitochondrial dysfunction (MESH:D028361), pain (MESH:D010146), Iron overload (MESH:D019190), morning stiffness (MESH:D048968), fibrosis (MESH:D005355), chronic inflammation (MESH:D007249), neurodegenerative, neoplastic, and autoimmune diseases (MESH:D019636), glioblastoma (MESH:D005909), synovial hyperplasia (MESH:D006965), destruction (MESH:D008105), dysfunction (MESH:D006331), tuberculosis (MESH:D014376), Chinese (MESH:C562377), osteoporosis (MESH:D010024), joint swelling (MESH:D007592), toxicity (MESH:D064420), bone destruction (MESH:D001847), bone erosion (MESH:D014077), foot swelling (MESH:D005530), synovial (MESH:D013581), gastrointestinal reactions (MESH:D005767), synovitis (MESH:D013585), infections (MESH:D007239), joint deformity (MESH:D016916), RA (MESH:D001172), iron metabolism (MESH:D019189), arthritis (MESH:D001168)
- **Chemicals:** 8-OHdG (MESH:D000080242), NO (MESH:D009569), SPN (MESH:C083178), Fuzi (MESH:C575009), Resveratrol (MESH:D000077185), iron (MESH:D007501), adalimumab (MESH:D000068879), methotrexate (MESH:D008727), lipid hydroperoxides (MESH:D008054), MDA (MESH:D015104), Cardamonin (MESH:C436747), flavone (MESH:C043562), Prussian blue (MESH:C000170), ibuprofen (MESH:D007052), JB (MESH:C057914), folic acid (MESH:D005492), ROS (MESH:D017382), short-chain fatty acids (MESH:D005232), diterpenoid (MESH:D004224), Lipid (MESH:D008055), LPS (MESH:D008070), butyric acid (MESH:D020148), GSH (MESH:D005978), Triptolide (MESH:C001899), selenium (MESH:D012643), Emodin (MESH:D004642), ICA (MESH:C056599), NADPH (MESH:D009249), imidazolidinone (MESH:C004916), SRI (MESH:D000093842), cystine (MESH:D003553), erastin (MESH:C477224), alpha-KG (MESH:D007656), bile acid (MESH:D001647), Curcumin (MESH:D003474), Achyranthes bidentata Blume (-), WOG (MESH:C085514), THDCA (MESH:C083510)
- **Species:** Artemisia vulgaris (common mugwort, species) [taxon 4220], Eucommia ulmoides (species) [taxon 4392], Chaenomeles speciosa (boke, species) [taxon 106546], Prunus mume (Japanese apricot, species) [taxon 102107], Scutellaria baicalensis (Baikal skullcap, species) [taxon 65409], Angelica sinensis (Chinese angelica, species) [taxon 165353], Ligusticum sinense [taxon 49555], Mus musculus (house mouse, species) [taxon 10090], Sinomenium acutum (species) [taxon 152363], Wolfiporia cocos (species) [taxon 81056], Ephedra sinica (cao ma-huang, species) [taxon 33152], Homalomena occulta (species) [taxon 714477], Panax notoginseng (notoginseng, species) [taxon 44586], Vespa magnifica (species) [taxon 202807], Artemisia argyi (species) [taxon 259893], Taxillus chinensis (species) [taxon 227909], Curcuma longa (turmeric, species) [taxon 136217], Homo sapiens (human, species) [taxon 9606], Elettaria cardamomum (cardamom, species) [taxon 105181], Rattus norvegicus (brown rat, species) [taxon 10116], Ligustrum lucidum (species) [taxon 458695], Euphorbia fischeriana (species) [taxon 1035560], Glycyrrhiza uralensis (Chinese licorice, species) [taxon 74613], Paeonia lactiflora (Chinese peony, species) [taxon 35924], Ptyas dhumnades (species) [taxon 8587]
- **Cell lines:** MH7A — Homo sapiens (Human), Transformed cell line (CVCL_0427), RAW264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), RA-FLS — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594), CIA-FLS — Homo sapiens (Human), Transformed cell line (CVCL_B2UU)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12960555/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12960555/full.md

## References

83 references — full list in the complete paper: https://tomesphere.com/paper/PMC12960555/full.md

---
Source: https://tomesphere.com/paper/PMC12960555